Development of a Nano-Emulsion Adjuvanted Intranasal Next-Generation Vaccine for COVID-19 & Influenza

Time: 5:00 pm
day: Pre-Conference Focus Day: Respiratory Infectious Disease Vaccine Development


  • Understanding how intranasal vaccine administration can lead to potent mucosal immunity currently absent in injectable vaccines
  • Demonstration of preclinical data to show strong immune responses from intranasal administration and immune mechanism of action